|
시장보고서
상품코드
2050883
대장암 치료제 시장 : 치료법별, 투여 경로별, 유통 채널별, 지역별Colorectal Cancer Therapeutics Market, By Therapy Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
대장암 치료제 시장은 2026년에 98억 달러로 추정되며, 2033년까지 135억 4,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 4.7%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 98억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 4.70% | 2033년 시장 규모 예측 : | 135억 4,000만 달러 |
대장암은 전 세계적으로 가장 흔한 암 중 하나이며, 암으로 인한 사망의 주요 원인입니다. 세계보건기구(WHO)에 따르면, 2021년에는 전 세계적으로 190만 건 이상의 새로운 대장암이 진단될 것으로 예상되며, 연간 90만 명 이상이 대장암으로 사망할 것으로 예측됩니다. 대장암의 유병률 증가와 제한된 치료 옵션으로 인해 효과적인 치료제에 대한 수요가 증가하고 있습니다. 많은 바이오제약사들이 대장암 치료를 위해 표적 단일클론항체, 단백질 키나아제 억제제, 면역관문억제제 등 새로운 표적치료제 개발에 집중하고 있습니다.
시장 역학
세계 대장암 치료제 시장의 성장은 전 세계 대장암 유병률 증가에 의해 주도되고 있습니다. 미국암협회에 따르면, 2021년 현재 미국에서는 매년 15만 명 이상의 대장암 환자가 새로 진단받고 있습니다. 또한, 대장암의 조기 발견 및 치료에 대한 인식 개선을 위한 정부 및 암 관련 단체의 노력이 증가함에 따라 시장 성장을 가속할 수 있습니다. 그러나 새로운 표적치료제에 따른 고비용은 그 보급을 저해하는 요인으로 작용할 수 있습니다. 차세대 바이오마커를 기반으로 한 맞춤형 치료제를 개발하기 위한 지속적인 연구개발은 수익성 높은 성장 기회를 창출할 수 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 대장암 치료제 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 세계 대장암 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 대장암 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 대장암 치료제 시장 : 요법 유형별, 2021년-2033년
제5장 대장암 치료제 시장 : 투여 경로별, 2021년-2033년
제6장 대장암 치료제 시장 : 유통 채널별, 2021년-2033년
제7장 대장암 치료제 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
LSH 26.06.15Colorectal Cancer Therapeutics Market is estimated to be valued at USD 9.80 Bn in 2026 and is expected to reach USD 13.54 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9.80 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.70% | 2033 Value Projection: | USD 13.54 Bn |
Colorectal cancer is one of the most common cancers worldwide and a leading cause of cancer-related mortality. According to World Health Organization (WHO), in 2021, over 1.9 million new cases of colorectal cancer are diagnosed globally and more than 0.9 million deaths due to colorectal cancer occur annually. Rising prevalence of colorectal cancer and limited treatment options have boosted demand for effective therapeutics. Several biopharma companies are focusing on developing novel targeted therapeutic approaches such as targeted monoclonal antibodies, protein kinase inhibitors, and immune checkpoint inhibitors to treat colorectal cancer.
Market Dynamics
Global colorectal cancer therapeutics market growth is driven by rising prevalence of colorectal cancer worldwide. In 2021, according to the American Cancer Society, over 150,000 new cases of colorectal cancer are diagnosed in the U.S. every year. Moreover, increasing initiatives by governments and cancer organizations to spread awareness about early detection and treatment of colorectal cancer can drive the market growth. However, high costs associated with novel targeted therapies can hamper its widespread adoption. Ongoing research & development for developing new generation biomarker-guided personalized therapies can create lucrative growth opportunities.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global colorectal cancer therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Sanofi, Bristol-Myers Squibb Company, Bayer AG, Ono Pharmaceutical Co. Ltd, ALX Oncology Inc., Daiichi Sankyo Company, Limited, Pfizer Inc., Exelixis, Inc., SOTIO Biotech AG, AB Science, BioNTech SE, Effector Therapeutics, Inc., and Treos Bio Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global colorectal cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global colorectal cancer therapeutics market
Market Segmentation
- Therapy Type Insights (Revenue, USD, 2021 - 2033)
- Chemotherapy
- Alkylating Agents
- Antimetabolites
- Others
- Immunotherapy
- Immune Checkpoint Inhibitors
- Oncolytic Virus Therapy
- Others
- Targeted Therapy
- Monoclonal antibodies
- Small molecule inhibitors
- Others
- Route of Administration Insights (Revenue, USD, 2021 - 2033)
- Oral
- Intravenous
- Intramuscular
- Subcutaneous
- Others
- Distribution Channel Insights (Revenue, USD, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Sanofi
- Bristol-Myers Squibb Company
- Bayer AG
- Ono Pharmaceutical Co. Ltd
- ALX Oncology Inc.
- Daiichi Sankyo Company, Limited
- Pfizer Inc.
- Exelixis, Inc.
- SOTIO Biotech AG
- AB Science
- BioNTech SE
- Effector Therapeutics, Inc.
- Treos Bio Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Colorectal Cancer Therapeutics Market, By Therapy Type
- Colorectal Cancer Therapeutics Market, By Route of Administration
- Colorectal Cancer Therapeutics Market, By Distribution Channel
- Colorectal Cancer Therapeutics Market, Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Epidemiology
- Pipeline Analysis
4. Colorectal Cancer Therapeutics Market, By Therapy Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Alkylating Agents
- Antimetabolites
- Others
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immune Checkpoint Inhibitors
- Oncolytic Virus Therapy
- Others
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Monoclonal antibodies
- Small molecule inhibitors
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Colorectal Cancer Therapeutics Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Colorectal Cancer Therapeutics Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Colorectal Cancer Therapeutics Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ono Pharmaceutical Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ALX Oncology Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Daiichi Sankyo Company, Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Exelixis, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SOTIO Biotech AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AB Science
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioNTech SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Effector Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Treos Bio Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
